针对HER2阳性早期乳腺癌的HER2向疗法:现在和未来
Luying Xu1,2, Yuxin Xie1,2, Qiheng Gou3
1Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Frontiers in pharmacology
|October 1, 2024
概括
针对HER2的药物可以改善HER2阳性早期乳腺癌 (HER2+ EBC) 的结果. 本综述详细介绍了它们的机制,耐药性和在HER2+EBC患者的临床使用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳腺癌 (BC) 是全球癌症死亡的主要原因.
- 在20-30%的BC患者中,HER2过度表达发生.
- 针对HER2的治疗方法改善了HER2阳性早期乳腺癌 (HER2+ EBC) 的治疗结果.
研究的目的:
- 系统地审查针对HER2+EBC的HER2向药物.
- 总结机制,耐药性,治疗方式和安全性.
- 提高对这些疗法的临床理解和应用.
主要方法:
- 系统的文献审查.
- 对HER2向药物机制的分析.
- 对治疗策略和安全概况的评估.
主要成果:
- 针对HER2的药物 (mAbs,TKIs,ADCs) 提高了治疗的有效性.
- 这些疗法改善了手术和缓解率.
- 在HER2+EBC患者中观察到术后复发风险降低.
结论:
- 针对HER2的药物对于控制HER2+EBC至关重要.
- 了解药物机制和耐药性是最佳使用的关键.
- 本综述为临床实践提供了全面的见解.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:30Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K